Financhill
Back

TG Therapeutics Stock Predictions

TG Therapeutics Stock Forecast

  • Over the next 52 weeks, TG Therapeutics has on average historically risen by 29.3% based on the past 28 years of stock performance.
  • TG Therapeutics has risen higher in 13 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 46.43%
  • Is TG Therapeutics Stock Undervalued?
    The current TG Therapeutics [TGTX] share price is $34.55. The Score for TGTX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • TGTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will TG Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, TG Therapeutics has on average historically risen by 29.3% based on the past 28 years of stock performance.

TG Therapeutics Stock Rating

Buy
62
TG Therapeutics (TGTX) is a Buy

Is TG Therapeutics overpriced?

  • TG Therapeutics has risen higher in 13 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 46.43%

TG Therapeutics Stock Price History

Is TGTX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TGTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
tgtherapeutics.com

52-Week Data

52-Week High:
36.50
52-Week Low:
12.26

Prediction Charts

Market Cap:
5.38B
Price in USD:
34.55
Volume:
5.83M
Beta:
0.95

Technical Analysis

SMA50:
25.37
SMA100:
23.36
SMA200:
19.57
52-Wk Change:
180.44%

Stock Predictions

  • Is TG Therapeutics stock public?
    Yes, TG Therapeutics is a publicly traded company.
  • What is the TG Therapeutics stock quote today?
    The TG Therapeutics stock price is 34.55 USD today.
  • How to buy TG Therapeutics stock online?
    You can buy TG Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-4 24.39 24.45 25.05 22.92
Nov-5 24.49 25.86 26.02 23.60
Nov-6 27.00 27.19 27.67 26.15
Nov-7 27.30 27.90 28.41 27.05
Nov-8 27.64 28.81 28.92 27.10
Nov-11 29.54 30.77 30.93 29.19
Nov-12 30.46 30.92 32.48 30.41
Nov-13 30.60 34.89 36.24 29.84
Nov-14 34.90 30.85 36.50 30.36
Nov-15 30.70 29.54 31.24 28.91
Nov-18 29.57 29.61 30.00 28.59
Nov-19 29.52 30.32 30.37 29.42
Nov-20 30.45 31.15 32.00 29.91
Nov-21 31.61 34.55 36.40 31.36

TG Therapeutics Earnings

TG Therapeutics Earnings Report: Per Share TG Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

TG Therapeutics Forecast Revenue Growth

TG Therapeutics Stock Analysis: Historical quarterly revenues per share for TG Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.73 per share.

* TG Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.